Skip to main content
. 2010 Mar 4;2010:613504. doi: 10.1155/2010/613504

Figure 1.

Figure 1

Summary of the tissues, cell populations, and bodily fluids that provide a source of discovery for biomarkers of prion infection (a). Schema to illustrate the stage-specific diagnostic and therapeutic windows for biomarker identification for diagnosis, disease progression, and monitoring pharmacological interventions (b).